BMJ2d
OP0132 TREAT-TO-TARGET APPROACH ALLOWS TO INDUCE SUSTAINED CLINICAL REMISSION IN OVER 60% OF PATIENTS WITH EARLY AXIAL SPONDYLOARTHRITIS
Background: Early therapeutic interventions in inflammatory rheumatic diseases have proven successful in inducing drug-free remission. However, such studies are difficult to conduct in axial ...
BMJ2d
POS0803 VUNAKIZUMAB IN ACTIVE ANKYLOSING SPONDYLITIS: A RANDOMIZED, DOUBLE-BLIND, ADAPTIVE, SEAMLESS, PHASE 2/3 STUDY
3 The First Affiliated Hospital of Guangxi Medical University, NanNing, China 4 The Second Affiliated Hospital of Guangxi Medical University, NanNing, China 5 The First Affiliated Hospital of ...
BMJ3d
AB0267 BODY COMPOSITION IN PATIENTS WITH RHEUMATOID ARTHRITIS
Background: Rheumatoid arthritis (RA) is a complex inflammatory disease that modifies body composition. Using the dual-energy x-ray absorptiometry (DXA) in RA patients could be a method for body ...
BMJ3d
POS0419 THE ROLE OF OROSOMUCOID 2 IN THE REGULATION OF BONE REMODELING BY INHIBITING OSTEOCLASTOGENESIS AND PROMOTING OSTEOGENESIS
1 Wonkwang University Medical School, Internal Medicine, Iksan, Korea, Rep. of (South Korea) 2 Jeonbuk National University Medical School, Internal Medicine, Jeonju, Korea, Rep. of (South Korea) ...
BMJ4d
AB1727 SERUM AND RENAL JANUS KINAS 3 EXPRESSION IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS
Background: Imbalance between pro and anti-inflammatory cytokines is an important feature in the pathogenesis of juvenile systemic lupus erythematosus (JSLE). Janus kinases (JAKs) play an important ...
BMJ4d
Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype
Several epidemiological and experimental data support the hypothesis that diabetes could be an independent risk factor for osteoarthritis (OA), at least in some patients, leading to the concept of a ...
BMJ4d
MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis
Institute of Medical Informatics and Statistics, University Hospital Schleswig-Holstein, Kiel, Germany Dr M Both, University Hospital Schleswig-Holstein, Campus Kiel, Department of Diagnostic ...
BMJ4d
Transplacental passage of belimumab during pregnancy and follow-up of a child exposed in utero
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ4d
Factors associated with long-term cardiac dysfunction in neonatal lupus
Objectives Cardiac manifestations of neonatal lupus (NL) have been associated with significant morbidity and mortality; however, there is minimal information on long-term outcomes of affected ...
BMJ5d
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
Correspondence to Martin Aringer, Medicine III, University Medical Center and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden D-01307, Germany; martin.aringer{at}uniklinikum-dresden.de; Dr ...
BMJ6d
Anti-inflammatory therapy for COVID-19 infection: the case for colchicine
Correspondence to Dr Michael H Pillinger, Rheumatology, New York University School of Medicine, New York, NY 10016, USA; Michael.Pillinger{at}nyulangone.org The search for effective COVID-19 ...
BMJ6d
SP0088 Hydrogels for Osteoarthritis Treatment
Osteoarthritis is a debilitating disease that affects cartilage and bone in joints. Cartilage injuries, if left untreated, are one of the leading risk factors for developing osteoarthritis. Thus, ...